Does ALS Run in Families?

The Direct Answer: 90% of ALS Cases Are Sporadic, But Genetics Still Play a Role

What 'Familial ALS' Means: Only 5-10% of Cases Are Inherited

Familial ALS (fALS) describes cases where at least one first-degree relative also had ALS, establishing a clear family history of the disease. It accounts for roughly 5-10% of all ALS cases, while the remaining 90-95% are classified as sporadic ALS (sALS), with no known family history. [1] A 2023 meta-analysis of 165 studies placed the pooled proportion of familial ALS among population-based studies at 5%, with variation by region and how fALS was defined -- suggesting the commonly cited 5-10% range reflects differences in study design and diagnostic criteria as much as true prevalence. [3] Understanding the [familial ALS inheritance pattern](https://alsunited.org/blog/familial-als-inheritance-pattern) helps families assess their risk, though both fALS and sALS are clinically identical in symptoms and progression. [2]

Why Sporadic ALS Can Still Have Genetic Components

The absence of a family history doesn't rule out a genetic contribution to ALS. De novo mutations -- new variants arising spontaneously rather than inherited -- have been confirmed as a cause of sporadic ALS, including cases linked to the SOD1 gene, where researchers identified four confirmed de novo mutations in patients with no family history of the disease. [4] Exome sequencing of sporadic ALS patients and their unaffected parents found de novo coding variants in 27% of cases, compound heterozygous recessive variants in another 27%, and homozygous recessive variants in 14% -- with 20% of patients carrying more than one of these. [5] Somatic mosaic mutations -- genetic changes present in only a small fraction of cells -- have also been detected in sporadic ALS, often confined to motor regions of the brain and undetectable through standard blood-based genetic screening. [6]

How Genetic Risk Differs from Guaranteed Inheritance

Carrying a gene mutation linked to ALS does not guarantee the disease will develop -- a concept known as reduced penetrance, which applies to all major ALS genes including C9orf72, SOD1, TARDBP, and FUS. [7] Some people who inherit a familial ALS mutation never develop symptoms at all, and researchers have not yet determined why some gene carriers develop the disease while others do not. [8] People with ALS-associated variants likely require additional genetic and environmental triggers before the disease manifests. [8] Experts describe ALS development as an interaction among genetic, epigenetic, and environmental factors -- meaning a positive genetic test reflects elevated risk, not a fixed outcome. [9]

Understanding Familial ALS: Inheritance Patterns and Your Family Risk

Autosomal Dominant Inheritance: 50% Chance Per Child in Familial ALS Families

Most familial ALS follows an autosomal dominant inheritance pattern, meaning one mutated copy of a gene -- from one parent -- is sufficient to elevate a person's risk of developing the disease. [8] Because the relevant genes sit on autosomes (chromosomes shared equally by males and females), this 50% inheritance risk applies to sons and daughters alike, with no difference based on sex. [10] Each child of a parent with familial ALS has a 50% chance of inheriting the mutation and a 50% chance of not inheriting it, with that probability applying independently to every pregnancy regardless of previous outcomes. [11] If a child does not inherit the mutation, they cannot pass it on to their own children. [10]

Genetic Penetrance and Why Some Carriers Never Develop ALS Symptoms

Penetrance describes the proportion of people carrying a given mutation who actually develop the associated disease -- and for ALS, that proportion shifts significantly by gene and by age. [12] For C9orf72, the most common mutation linked to familial ALS, penetrance is estimated at 60% by age 60 and rises to 91% by age 80, meaning a meaningful share of carriers will never develop symptoms within their lifetime. [12] SOD1 mutations show similar variability -- certain variants carry penetrance above 95% by age 78, while others, such as the p.D91A variant, remain considerably lower. [12] Factors that influence whether a carrier develops ALS include the size of the genetic expansion, DNA methylation, epigenetic changes, and the presence of additional mutations elsewhere in the genome -- which is why a positive genetic result reflects risk, not certainty. [12]

What Family History Screening Looks Like: Identifying Patterns Across Generations

Family history screening for ALS typically begins with a three-generation pedigree that records diagnoses of ALS, dementia, and Parkinsonism in relatives, along with ages of onset and death for each affected individual. [13] Medical records -- and autopsy reports where available -- help confirm diagnoses, since apparently sporadic cases can sometimes reflect incomplete family information, early deaths among mutation carriers, or misdiagnosed relatives rather than a true absence of hereditary risk. [13] A genetic counselor who specializes in neurogenetics can guide families through building this pedigree, help interpret what it reveals, and determine whether genetic testing is appropriate based on the specific pattern of illness across generations. [14] Our [clinic finder](https://www.alsunited.org/) connects families with ALS specialists and genetic counselors who are ready to support you through every step of this process.

What Causes ALS in People Without Family History: Environmental and Lifestyle Factors

Known Environmental Risk Factors: Military Service, Occupational Toxins, and Brain Injury

Military service carries one of the strongest documented environmental links to ALS, with veterans showing approximately 1.34 times the risk of developing the disease compared to civilians. [16] Rates among deployed Gulf War veterans were roughly double those of non-deployed personnel, with researchers pointing to burn pits, diesel exhaust, pesticides, and heavy metals as likely contributors to that elevated risk. [15] Occupational toxin exposure -- particularly pesticides (OR = 1.96) and lead (OR = 2.31) -- also shows consistent associations with ALS onset across multiple studies, and these exposures are thought to act as steps in a multistep disease process rather than single causes. [16] Head trauma rounds out the core environmental risk profile, carrying a pooled odds ratio of 1.26, with evidence that a head injury within 15 years before diagnosis may more than double ALS risk in some cohorts. [16]

Lifestyle Factors That May Increase ALS Risk: Smoking, Physical Trauma, and Exercise Intensity

Smoking raises ALS risk by more than 40% compared to non-smokers, with Mendelian randomization evidence indicating this association is causal rather than incidental. [17] The relationship between high-intensity exercise and ALS is more layered: Mendelian randomization and transcriptomic data show that genetic liability to frequent, strenuous leisure-time exercise is a causal risk factor for ALS, though the association appears strongest among people who carry ALS-related mutations such as C9orf72 -- pointing to a gene-environment interaction rather than a universal hazard. [18] Recreational physical activity does not carry the same risk elevation as professional or competitive sport, and there is emerging evidence that moderate exercise may support motor neuron health in some individuals. [18] If you are navigating a known genetic risk, our resource on [ALS prevention strategies](https://alsunited.org/blog/how-to-prevent-als-someday-current-research-and-strategies) outlines what current research does and does not support for reducing exposure to modifiable risk factors.

How to Lower Your Chances of Developing ALS: What the Research Shows

No single action can reliably prevent ALS, but reducing exposure to identified risk factors is the most evidence-based step currently available. Quitting smoking, limiting pesticide and heavy metal exposure, and protecting against head trauma address the contributors with the strongest research support. [19][20] An umbrella review of 43 meta-analyses found convincing evidence that regular use of antihypertensive medications is associated with lower ALS risk (OR: 0.85), and a higher premorbid body mass index showed a modest protective association -- findings researchers attribute to metabolic and vascular mechanisms that affect motor neuron health. [20] Because ALS prevention science is still developing and no strategy is foolproof, our resource on [ALS prevention strategies](https://alsunited.org/blog/how-to-prevent-als-someday-current-research-and-strategies) outlines what current evidence supports and how to discuss modifiable risks with your care team. [21]

Getting Support and Answers: Next Steps If ALS Runs in Your Family or You're at Risk

Genetic Testing and Counseling: What to Expect and Where to Start

Genetic testing for ALS typically involves three counseling stages: a predecision session to assess readiness and explore motivations, a pretest session covering gene-specific information and legal considerations (including insurance implications under current US law), and a posttest session to interpret results and discuss what they mean for you and your family. [22] Testing is always voluntary -- you can decline, provide a DNA sample for research only, or undergo testing without ever receiving the results. [22] Sessions can be conducted by phone or video for families who can't travel to a specialist center, and testing generally focuses on mutations already confirmed in affected relatives rather than a broad screen of all known ALS genes. [22] If your family has a confirmed or suspected hereditary case, connecting with a genetic counselor who specializes in ALS genetics is the most important first step -- we are here for you throughout that process. [23]

Recognizing Early ALS Symptoms: Age of Onset and First Warning Signs to Watch For

ALS most often develops in adults, though a rare childhood form linked to the SPTLC1 gene can affect children as young as 4. [26] The earliest warning signs are typically subtle: muscle weakness or stiffness in the hands, feet, arms, or legs, twitching (fasciculations), slurred speech, or trouble swallowing. [24] Symptoms tend to begin in one part of the body before spreading, and pain is not common in the early stages. [24] Because early ALS signs can resemble other conditions, reviewing [very early ALS symptoms](https://alsunited.org/blog/very-early-als-symptoms-what-to-look-out-for) before seeing a specialist can help ensure nothing gets overlooked. [25]

Building Your Support Network: How ALS United Connects Families to Resources and Community

Families who receive a positive genetic result often need support that extends well beyond a single counseling session -- the emotional weight of that information tends to grow over time, particularly as family planning decisions and conversations with relatives come into focus. [10] Peer support programs connect at-risk individuals and families with others who have navigated the same questions around testing, disclosure, and what a hereditary diagnosis means across generations, offering a form of guidance that clinical appointments alone cannot provide. [27] Familial ALS advocacy communities actively engage and empower families by keeping them informed about research developments, emerging clinical trials relevant to hereditary cases, and evolving therapies targeted at specific gene mutations. [28] Our [ALS support resources](https://alsunited.org/blog/als-support-essential-resources-for-patients-and-families/) bring together medical guidance, emotional support, and community connection -- because together in the fight, no family should have to navigate hereditary ALS alone.